The Irvine, Calif.-based company said 3 unnamed investors participated in the equity round, which aims to raise a total of nearly $8.5 million, according to a regulatory filing.
Harbor developed a technique it calls “Bridge” to transform biologic substrates into regenerative medicine products. Its Architect stabilized collagen matrix is designed to treat complex skin wounds; the EPMatrix product is designed for surgeries to repair soft tissue injuries.
Although both products begin as highly organized Type I collagen from xenografts, the Bridge process “cleans” the grafts of intra-cellular debris and preserves extra-cellular matrix fibers, growth factors and other natural tissue proteins. The company says this improves bio-compatibility, prevents rapid degradation and encourages tissue regeneration.
The post Harbor MedTech raises $5m for regenerative soft tissue repair tech appeared first on MassDevice.
from MassDevice http://ift.tt/2e9Z2ks
Cap comentari:
Publica un comentari a l'entrada